Skip to main content
. 2019 Jan 11;98(2):e14091. doi: 10.1097/MD.0000000000014091

Figure 5.

Figure 5

The synthesized HR assessing the prognostic value of pretreatment LMR for OS in bladder cancer. LMR = lymphocyte-to-monocyte ratio, OS = overall survival.